NEW YORK (GenomeWeb News) – Myriad Genetics said after the close of the market on Monday that it has signed an agreement to provide its BRACAnalysis test as a companion diagnostic for a cancer therapeutic being developed by Tesaro.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: comprehensive analysis of somatic mutations in breast cancer, and more.
A number of studies indicate that genes might influence political beliefs, Scientific American Mind reports.
Craig Venter's Human Longevity is deeply phenotyping individuals and capturing their genetic profiles to explore aging.
The San Francisco Business Times examines Verily's latest hires.